JPH07118135A - Cosmetic - Google Patents

Cosmetic

Info

Publication number
JPH07118135A
JPH07118135A JP5261128A JP26112893A JPH07118135A JP H07118135 A JPH07118135 A JP H07118135A JP 5261128 A JP5261128 A JP 5261128A JP 26112893 A JP26112893 A JP 26112893A JP H07118135 A JPH07118135 A JP H07118135A
Authority
JP
Japan
Prior art keywords
cosmetic
activity
skin
hyaluronidase
ethanol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP5261128A
Other languages
Japanese (ja)
Other versions
JP3235919B2 (en
Inventor
Tsuneo Nanba
恒雄 難波
Yukio Hattori
征雄 服部
Kenji Shimomura
健次 下村
Masami Nakamura
雅美 中村
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mikimoto Pharmaceutical Co Ltd
Original Assignee
Mikimoto Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mikimoto Pharmaceutical Co Ltd filed Critical Mikimoto Pharmaceutical Co Ltd
Priority to JP26112893A priority Critical patent/JP3235919B2/en
Publication of JPH07118135A publication Critical patent/JPH07118135A/en
Application granted granted Critical
Publication of JP3235919B2 publication Critical patent/JP3235919B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Abstract

PURPOSE:To obtain a cosmetic containing solvent extracts of Adhatoda vasica used for food over long years and being safe to human body as active ingredients, having large whitening action and inhibiting the activity of hyaluronidase. CONSTITUTION:This cosmetic contains extracts obtained by extracting Adhatoda vasica which is an evergreen short tree being a plant of Acanthaceae and cultured in the tropics with water or ethanol or mixed solvent thereof as active ingredients. The cosmetic has high whitening action and inhibits hyaluronidase activity and it is effective in chapped skin and high in safety. This cosmetic can be prepared in various types of cosmetics, e.g. lotion, cream, milky lotion and pack by blending this cosmetic with other cosmetic raw material, e.g. squalane, jojoba oil, beeswax, cetyl alcohol, various kinds of activating agents, humectant such as glycerin and various kinds of medicines, etc. This cosmetic suppresses tyrosinase activity, hyaluronidase activity and active oxygen and it is effective in chapped skin or tension of skin.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【産業上の利用分野】本発明は、美白作用が高く、ヒア
ルロニダーゼの活性を阻害し、且つ肌荒れなどに有効な
安全性の高い化粧料に関する。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a cosmetic composition which has a high whitening effect, inhibits the activity of hyaluronidase and is effective against rough skin.

【0002】[0002]

【従来の技術】アダトダ・バシカ(Adhatoda vasica)
は、キツネノマゴ科アダトダ属の植物でインドのパンジ
ャブ地方、アッサム地方からスリランカ、シンガポール
に分布し、熱帯各地で栽培される常緑低木である。この
アダトダ・バシカは、インドなどでは喘息、発熱、黄
疸、浄血などの治療薬として2000年以上も前から使
用されてきた重要な薬用植物である。
[Prior Art] Adhatoda vasica
Is a plant belonging to the genus Adatoda of the family Lepidoptera, distributed in Punjab, Assam, India, Sri Lanka, and Singapore, and is an evergreen shrub cultivated in various tropical regions. This adatda bashika is an important medicinal plant that has been used for over 2000 years as a therapeutic drug for asthma, fever, jaundice, blood purification, etc. in India.

【0003】一方、化粧料の原料として使用できる美白
作用のある物質としては、種々の物質が知られている
が、合成品は、長期間人間の肌に適用した場合の安全性
の保証がなく、使用が制限されつつある。他方、天然物
では美白作用が弱いものが多い。しかし、人の肌に対す
る安全性の面から天然物で、多年、人が食したりして、
安全性の面で保証されており、しかも美白作用が強く、
更に皮膚に対する他の効果も合わせもつ物質が望まれて
いた。
On the other hand, various substances are known as substances having a whitening effect which can be used as a raw material for cosmetics, but synthetic products have no guarantee of safety when applied to human skin for a long period of time. , Its use is being limited. On the other hand, many natural products have a weak whitening effect. However, from the viewpoint of safety for human skin, it is a natural product, and people eat it for many years,
Guaranteed in terms of safety and strong whitening effect,
Furthermore, a substance that also has other effects on the skin has been desired.

【0004】[0004]

【発明が解決しようとする課題】本発明の目的は、皮膚
に適用して安全であると共に、美白作用が大きく且つヒ
アルロニダーゼの活性を阻害し、更に肌荒れなどに有効
な成分を含んだ化粧料を提供することにある。
The object of the present invention is to provide a cosmetic composition which is safe when applied to the skin, has a large whitening effect, inhibits the activity of hyaluronidase, and further contains an ingredient effective for rough skin and the like. To provide.

【0005】[0005]

【課題を解決するための手段】本発明者らは、前記の課
題を解決するために、すでに多年にわたって食用に供さ
れ、人体に対する安全性が確認されている植物をスクリ
ーニングして調べ、化粧料として利用価値のあるものを
検討した。その結果、アダトダ・バシカが化粧品原料と
して、或いは医薬部外品としての有効性を有することを
見い出して本発明を完成するに至ったのである。すなわ
ち、本発明は、アダトダ・バシカの溶媒抽出物を含む化
粧料である。
[Means for Solving the Problems] In order to solve the above-mentioned problems, the present inventors have screened and investigated plants that have been used for food for many years and have been confirmed to be safe for the human body. I examined what is useful as. As a result, they have found that Adatoda bashika is effective as a raw material for cosmetics or as a quasi drug, and completed the present invention. That is, the present invention is a cosmetic containing a solvent extract of Adatda bashika.

【0006】[0006]

【作用】本発明の化粧料として用いられるアダトダ・バ
シカの溶媒抽出物の確認された作用は、第1に肌の美白
作用、第2にヒアルロニダーゼの活性抑制作用、第3に
活性酸素抑制作用、第4に抗酸化作用である。上記第2
のヒアルロニダーゼの活性抑制作用について更に詳しく
説明する。ヒアルロニダーゼは、生体中に広く分布し、
皮膚にも存在する酵素であり、その名のとおりヒアルロ
ン酸を分解する。ヒアルロン酸は、β−D−N−アセチ
ルグルコサミンとβ−D−グルクロン酸が交互に結合し
た直鎖状の高分子多糖で、コンドロイチン硫酸などとと
もに哺乳動物の結合組織に広く存在するグリコサミノグ
ルカンの一種である。結合組織内でのヒアルロン酸の作
用としては、細胞間隙に水分を保持し、また組織内にジ
ェリー状のマトリックスを形成して細胞を保持したり、
皮膚の潤滑性と柔軟性を保ち、外力(機械的障害)およ
び細菌感染を防止していると考えられている。また、皮
膚のヒアルロン酸は齢をとるにつれて減少し、その結果
小ジワやかさつきなどの老化をもたらすといわれてい
る。従って、このヒアルロン酸を分解するヒアルロニダ
ーゼの活性を抑制することは、製剤に使用されているヒ
アルロン酸の安定性や、皮膚に塗布した後の製剤のヒア
ルロン酸及び皮膚に存在していたヒアルロン酸の安定に
寄与すると考えられる。
The action of the solvent extract of Adatda vashika used as the cosmetic of the present invention is as follows: first, the skin whitening action, second, the hyaluronidase activity suppressing action, and the third, active oxygen suppressing action, Fourth is the antioxidant effect. Second above
The activity of hyaluronidase for suppressing the activity will be described in more detail. Hyaluronidase is widely distributed in the living body,
It is an enzyme that is also present in the skin, and as its name implies, it decomposes hyaluronic acid. Hyaluronic acid is a linear polymer polysaccharide in which β-D-N-acetylglucosamine and β-D-glucuronic acid are alternately bound, and is a glycosaminoglucan that widely exists in connective tissues of mammals along with chondroitin sulfate and the like. Is a kind of. The action of hyaluronic acid in connective tissue is to retain water in the intercellular spaces, form a jelly-like matrix in the tissue to retain cells,
It is thought to maintain the lubricity and flexibility of the skin and prevent external forces (mechanical damage) and bacterial infections. In addition, it is said that hyaluronic acid in the skin decreases with age, resulting in aging such as wrinkles and bulkiness. Therefore, suppressing the activity of hyaluronidase that decomposes this hyaluronic acid, the stability of hyaluronic acid used in the formulation, the hyaluronic acid of the formulation after application to the skin and the hyaluronic acid present in the skin It is thought to contribute to stability.

【0007】また、上記第3の活性酸素抑制作用につい
て更に詳しく説明する。一般に、空気中に酸素がないと
生物(嫌気性のものを除く)は存在しえない。しかし、
酸素は紫外線や酵素等の影響を受けて活性酸素になる。
この活性酸素は、脂肪酸を酸化し過酸化物を生成させ
る。生体の生体膜のリン脂質も酸化させ、障害を与え
る。その上、生成した過酸化物と活性酸素はDNAに損
傷を与え、老化を促進するといわれている。この活性酸
素は、チロシンからメラニンを作る機構にも影響を与え
皮膚の黒化にも関与している。この活性酸素を抑制する
ことは皮膚にとって重要な、言い換えれば化粧料に求め
られる重要な要素である。
The third active oxygen suppressing action will be described in more detail. Generally, no organisms (except anaerobic ones) can exist without oxygen in the air. But,
Oxygen becomes active oxygen under the influence of ultraviolet rays and enzymes.
This active oxygen oxidizes a fatty acid and produces a peroxide. It also oxidizes and damages the phospholipids of biological membranes in the body. Furthermore, it is said that the generated peroxide and active oxygen damage DNA and accelerate aging. This active oxygen also influences the mechanism of making melanin from tyrosine and is also involved in the blackening of the skin. Suppressing this active oxygen is an important factor for the skin, in other words, an important factor required for cosmetics.

【0008】アダトダ・バシカの利用方法としては、水
或いは親水性有機溶媒、例えば、エタノール、メタノー
ル、アセトン等で抽出する。しかしながら、化粧品原料
の抽出であるから、水、或いはエタノール又はこれらの
混合溶媒での抽出が好ましいのは当然である。また、場
合によっては、グリセリン、1,3−ブチレングリコー
ル、プロピレングリコール等の多価アルコール又は多価
アルコールと水の混液も抽出に利用できる。さらにま
た、凍結乾燥して粉体として利用することも利用方法に
よっては有効である。
As a method for utilizing Adatda bashika, extraction is carried out with water or a hydrophilic organic solvent such as ethanol, methanol or acetone. However, it is natural that extraction with water, ethanol, or a mixed solvent thereof is preferable because it is extraction of cosmetic raw materials. In some cases, a polyhydric alcohol such as glycerin, 1,3-butylene glycol, propylene glycol or a mixed liquid of polyhydric alcohol and water can be used for extraction. Furthermore, freeze-drying and using it as a powder is also effective depending on the method of use.

【0009】この物質を他の化粧品原料、例えば、スク
ワラン、ホホバ油等の液状油、ミツロウ、セチルアルコ
ール等の固体油、各種の活性剤、グリセリン、1,3ー
ブチレングリコール等の保湿剤や各種薬剤等を配合して
様々な剤形の化粧料、例えば、ローション、クリーム、
乳液、パック等に調製でき、目的に応じて種々の利用形
態の化粧料などに調製することができる。
This substance is used as a raw material for other cosmetics, for example, liquid oils such as squalane and jojoba oil, solid oils such as beeswax and cetyl alcohol, various activators, humectants such as glycerin and 1,3-butylene glycol and various Cosmetics of various dosage forms such as lotions, creams, etc.
It can be prepared into a milky lotion, a pack or the like, and can be prepared into cosmetics of various usage forms according to the purpose.

【0010】[0010]

【実施例】以下に、本発明で使用するアダトダ・バシカ
の抽出物の製造例、実際の利用方法である実施例を記載
するが、本発明はこれらの製造例及び実施例によって何
ら限定されるものではない。
[Examples] The following is a description of production examples of the extract of Adatda vashika used in the present invention and examples of actual utilization methods, but the present invention is in no way limited by these production examples and examples. Not a thing.

【0011】〔製造例1〕アダトダ・バシカの材(乾燥
品)を10gにエタノール300mlを加えて時々撹拌し
つつ5日間放置した。これを濾過後凍結乾燥した。
[Production Example 1] To 10 g of the Adatda vashika wood (dry product) was added 300 ml of ethanol, and the mixture was left for 5 days with occasional stirring. This was filtered and freeze-dried.

【0012】〔製造例2〕アダトダ・バシカの材(乾燥
品)を10gに50%エタノール水溶液300mlを加え
て時々撹拌しつつ5日間放置した。これを濾過後凍結乾
燥した。
[Production Example 2] To 10 g of Adatda vashika wood (dry product) was added 300 ml of 50% ethanol aqueous solution, and the mixture was left for 5 days with occasional stirring. This was filtered and freeze-dried.

【0013】〔製造例3〕アダトダ・バシカの材(乾燥
品)を10gに精製水300mlを加えて3時間加熱す
る。これを放冷した後濾過後凍結乾燥した。
[Production Example 3] To 10 g of Adatda vashika wood (dry product), 300 ml of purified water was added and heated for 3 hours. This was allowed to cool, then filtered and freeze-dried.

【0014】〔実施例1(ローションの調製)〕下記の
諸成分を混合して、常法によりローションを調製した。 (重量%) オリーブ油 0.5 製造例1のアダトダ・バシカの材のエタノール抽出物 0.5 ポリオキシエチレン(20E.O.)ソルビタンモノステアレート 2.0 ポリオキシエチレン(60E.O.)硬化ヒマシ油 2.0 エタノール 10.0 1.0%ヒアルロン酸ナトリウム水溶液 5.0 精製水 80.0
[Example 1 (Preparation of lotion)] The following components were mixed to prepare a lotion by a conventional method. (% By weight) Olive oil 0.5 Ethanol extract of Adatda vashika wood of Production Example 0.5 Polyoxyethylene (20 E.O.) sorbitan monostearate 2.0 Polyoxyethylene (60 E.O.) Hardened Castor oil 2.0 Ethanol 10.0 1.0% sodium hyaluronate aqueous solution 5.0 Purified water 80.0

【0015】〔実施例2(クリームの調製)〕下記諸成
分からなるAとBとをそれぞれ70℃まで加温し、次い
で、BにAを撹拌しつつ徐々に加えた後、ゆっくりと撹
拌しつつ30℃まで冷却してクリームを調製した。 (重量%) A スクワラン 20.0 オリーブ油 2.0 ミンク油 1.0 ホホバ油 5.0 ミツロウ 5.0 セトステアリルアルコール 2.0 グリセリンモノステアレート 1.0 ソルビタンモノステアレート 2.0 製造例2のアダトダ・バシカの材の50%エタノール抽出物 1.0 B 精製水 47.9 ポリオキシエチレン(20E.O.)ソルビタンモノステアレート 2.0 ポリオキシエチレン(60E.O.)硬化ヒマシ油 1.0 グリセリン 5.0 1.0%ヒアルロン酸ナトリウム水溶液 5.0 パラオキシ安息香酸メチル 0.1
[Example 2 (Preparation of cream)] A and B each consisting of the following components were heated to 70 ° C., and then A was slowly added to B with stirring and then slowly stirred. While cooling to 30 ° C, a cream was prepared. (Wt%) A squalane 20.0 Olive oil 2.0 Mink oil 1.0 Jojoba oil 5.0 Beeswax 5.0 Cetostearyl alcohol 2.0 Glycerin monostearate 1.0 Sorbitan monostearate 2.0 Production example 2 50% ethanol extract of Adatoda bashika wood 1.0 B Purified water 47.9 Polyoxyethylene (20 E.O.) sorbitan monostearate 2.0 Polyoxyethylene (60 E.O.) hydrogenated castor oil 1 0.0 Glycerin 5.0 1.0% sodium hyaluronate aqueous solution 5.0 Methyl paraoxybenzoate 0.1

【0016】〔実施例3(クリームの調製)〕実施例2
の製造例2の抽出物を製造例3の抽出物に変えて調製し
た。
[Example 3 (Preparation of cream)] Example 2
Was prepared by replacing the extract of Production Example 2 of Example 2 with the extract of Production Example 3.

【0017】〔チロシナーゼ活性阻害〕 (試験方法)マックルバルン(Mcllvaln)緩衝液0.9m
l、1.66mMチロシン(Tyrosine)溶液1.0ml、前記製
造例(凍結乾燥品)の0.1wt/v%水溶液(溶解しにく
い場合はエタノールを加えて溶解したのち精製水を加え
て、エバポレートし、エタノール除去したのち、0.1w
t/v%になるように調製した)1.0mlをスクリューバイ
アルにとり、37℃恒温水槽中で5分以上加温した。チ
ロシナーゼ溶液(Sigma社製、マッシュルーム由来、914
ユニット/ml)0.1mlを加え、37℃恒温水槽中で保温
し、10分後に475nmで吸光度を測定した。対照とし
て、上記試料液のかわりに純水を加え同様に測定した。
この試験では試料の終濃度は0.033%となる。 (計算式) チロシナーゼ活性阻害率(%)={B−(A−P)}/
B×100 ただし、A:試料検体の吸光度 B:対照の吸光度 P:試料検体の着色による吸光度(3倍希釈)
[Inhibition of tyrosinase activity] (Test method) McClevaln buffer solution 0.9 m
l, 1.66 mM Tyrosine solution 1.0 ml, 0.1 wt / v% aqueous solution of the above production example (freeze-dried product) (if it is difficult to dissolve, add ethanol and dissolve, then add purified water and evaporate , After removing ethanol, 0.1w
1.0 ml (prepared to be t / v%) was placed in a screw vial and heated in a 37 ° C. constant temperature water bath for 5 minutes or more. Tyrosinase solution (Sigma, mushroom-derived, 914
0.1 unit (ml / ml) was added, and the temperature was kept in a 37 ° C. constant temperature water bath, and after 10 minutes, the absorbance was measured at 475 nm. As a control, pure water was added instead of the sample solution and the same measurement was performed.
In this test, the final concentration of the sample is 0.033%. (Calculation formula) Tyrosinase activity inhibition rate (%) = {B- (AP)} /
B × 100 However, A: Absorbance of sample specimen B: Absorbance of control P: Absorbance due to coloring of sample specimen (3-fold dilution)

【0018】[0018]

【表1】 [Table 1]

【0019】〔ヒアルロニダーゼ活性抑制試験〕 (試験方法)0.4%ヒアルロン酸ナトリウム0.1M
(pH6.0)リン酸緩衝溶液6gを計量し、37℃の
恒温水槽で5分間放置した後、前記製造例(凍結乾燥
品)の0.1wt/v%水溶液(溶解しにくい場合はエタノ
ールを加えて溶解したのち精製水を加えて、エバポレー
トし、エタノール除去したのち、0.1wt/v%になるよ
うに調製した)1.0mlを加え撹拌し、0.01%ヒア
ルロニダーゼ(シグマ社製 牛睾丸製、タイプI−S)
0.1M(pH6.0)リン酸緩衝液を1ml加えて直
ちに撹拌し、6mlを37℃の恒温水槽に入れたオストワ
ルド粘度計に入れた。これを1分後、5分後、10分
後、20分後、40分後に粘度を測定した。対照とし
て、上記試料液の代わりに純水を加え同様にして測定し
た。この試験では試料の終濃度は、それぞれ検体の濃度
の0.0125%となる。1分後の粘度を100とし
て、それぞれの結果を指数で下記表2に示す。
[Hyaluronidase activity inhibition test] (Test method) 0.4% sodium hyaluronate 0.1M
(PH 6.0) 6 g of phosphate buffer solution was weighed and allowed to stand in a 37 ° C. constant temperature water bath for 5 minutes, and then 0.1 wt / v% aqueous solution of the above production example (lyophilized product) In addition, after dissolving, purified water was added to the solution to evaporate it, and ethanol was removed. Then, the solution was adjusted to 0.1 wt / v%. 1.0 ml was added and stirred, and 0.01% hyaluronidase (manufactured by Sigma) Made of testicles, type I-S)
1 ml of 0.1 M (pH 6.0) phosphate buffer was added and immediately stirred, and 6 ml was placed in an Ostwald viscometer placed in a 37 ° C. constant temperature water bath. The viscosity was measured after 1 minute, 5 minutes, 10 minutes, 20 minutes, and 40 minutes. As a control, pure water was added instead of the above sample solution, and the same measurement was performed. In this test, the final concentration of each sample is 0.0125% of the concentration of the analyte. The results are shown in Table 2 below as an index, with the viscosity after 1 minute being 100.

【0020】[0020]

【表2】 [Table 2]

【0021】〔活性酸素抑制試験〕活性酸素を抑制する
効果を測定する方法は各種あるが、今回以下の方法を利
用した。 pH7.8 50mMリン酸カリウム緩衝液(1.3mM DETAPAC含有) 133ml 40 unit/ml カタラーゼの上記のリン酸カリウム緩衝液 5ml 2mM ニトロブルーテトラゾリウムの上記のリン酸カリウム緩衝液 5ml 1.8mM キサンチンの上記のリン酸カリウム緩衝液 17ml 160ml
[Active Oxygen Suppression Test] There are various methods for measuring the effect of suppressing active oxygen, but the following method was used this time. pH 7.8 50 mM potassium phosphate buffer (containing 1.3 mM DETAPAC) 133 ml 40 unit / ml Catalase above potassium phosphate buffer 5 ml 2 mM Nitroblue tetrazolium above potassium phosphate buffer 5 ml 1.8 mM Xanthine above phosphorus Potassium acid buffer 17 ml 160 ml

【0022】上記の試薬の混合物を2.4ml、検体を0.3ml
加えて キサンチンオキシナーゼ(予め検体を水とし、
実験するとき、吸光度が1分当たり)0.02前後上昇する
ように上記のリン酸カリウム緩衝液で調整しておく)液
を0.3ml加えて直ちに吸光度(560nm)を測定する(測定
は2分位し、直線性を確認する)。 (計算式) 阻害率={(A−B)/A}×100 ただし、A:検体を水としたときの1分当たりの吸光度
の変化 B:検体の1分当たりの吸光度の変化 濃度段階を数段階行い、50%活性酸素生成阻害濃度を
探した。検体の作成方法は前記製造例(凍結乾燥品)を
適当な濃度の水溶液を調製(溶解しにくい場合はエタノ
ールを加えて溶解したのち精製水を加えて、エバポレー
トし、エタノールを除去したのち適当な濃度%となるよ
うに調製)した。製造例1、2についての結果を次の表
3に示す。
2.4 ml of the mixture of the above reagents and 0.3 ml of the sample
In addition, xanthine oxidase (using water as the sample beforehand,
When conducting an experiment, add 0.3 ml of the above solution so that the absorbance will increase to around 0.02 per minute (adjusted with the above potassium phosphate buffer solution) and immediately measure the absorbance (560 nm) , Check the linearity). (Calculation formula) Inhibition rate = {(A−B) / A} × 100 where A: change in absorbance per minute when the sample is water B: change in absorbance per minute of sample Several steps were carried out to find the 50% active oxygen production inhibitory concentration. The preparation method of the sample is to prepare an aqueous solution of the above preparation example (freeze-dried product) at an appropriate concentration (if it is difficult to dissolve, add ethanol and dissolve it, then add purified water and evaporate to remove ethanol. It was prepared so that the concentration became%). The results for Production Examples 1 and 2 are shown in Table 3 below.

【0023】[0023]

【表3】 [Table 3]

【0024】〔抗酸化試験〕下記のネジキャップ付50
ml試験管に作製した。 検体 5ml 2%リノール酸エタノール溶液 10ml 0.1M、pH7.0リン酸緩衝液 10ml 精製水 5ml このネジキャップ付50ml試験管を50℃の恒温槽に遮
光して放置する。これを恒温槽に入れる前、3日後、6
日後、8日後に下記の測定をした。試験液0.125m
l、75%エタノール12.125ml、30%チオシ
アン酸アンモニウム0.125mlを加えて撹拌し3分
間放置後、0.02N塩化第一鉄3.5%HCL水溶液
0.125mlを加えて撹拌し3分間放置後、波長50
0nmで吸光度を測定した。セル長10mm、対照セル
は試験液を水に置き換えたもの。その結果を次の表4、
5に示す。
[Antioxidant test] With the following screw cap 50
Made into ml test tubes. Specimen 5 ml 2% linoleic acid ethanol solution 10 ml 0.1 M, pH 7.0 phosphate buffer 10 ml Purified water 5 ml This 50 ml test tube with a screw cap is left in a thermostat bath at 50 ° C in the dark. Before putting this in a constant temperature bath, 3 days later, 6
The following measurements were made after 8 days. Test solution 0.125m
1, 12.25 ml of 75% ethanol and 0.125 ml of 30% ammonium thiocyanate were added and stirred and left for 3 minutes, and then 0.125 ml of 0.02N ferrous chloride 3.5% HCL aqueous solution was added and stirred for 3 minutes. Wavelength 50 after leaving
Absorbance was measured at 0 nm. The cell length was 10 mm, and the control cell had the test solution replaced with water. The results are shown in Table 4 below.
5 shows.

【0025】[0025]

【表4】 [Table 4]

【0026】[0026]

【表5】 [Table 5]

【0027】(使用テスト)女性6名の顔面を左右に分
け、一方に、実施例のローションとクリームをセットに
して、他方には比較例のローションとクリームをセット
にして毎日、1回以上使用してもらって、3カ月後に、
美白、肌荒れ防止、肌のつや及び肌のはりについて評価
した。なお、比較例は実施例より製造例の各種のアダト
バ・バシカの抽出物を水に代えたものである(比較例
1、2)。なお、12名を2班にわけ、下記表6に示さ
れる試料を使って試験した。
(Usage Test) Faces of 6 women were divided into left and right sides, and the lotion and cream of the example were set on one side, and the lotion and cream of the comparative example were set on the other side and used once or more daily. After three months,
The whitening, the prevention of rough skin, the gloss of the skin and the suppleness of the skin were evaluated. In addition, the comparative example is the one in which the various extracts of Adatoba bashika in the production examples are replaced with water in the production examples (Comparative Examples 1 and 2). In addition, 12 people were divided into 2 groups and tested using the samples shown in Table 6 below.

【0028】[0028]

【表6】 [Table 6]

【0029】評価は、下記の評価基準により評価し、そ
の結果の評点を合計した値をまとめたのが下記の表7で
ある。 (評価基準) 実施例の方が非常によい 3 実施例の方がかなりよい 2 実施例の方がややよい 1 差がない 0 比較例の方がややよい −1 比較例の方がかなりよい −2 比較例の方が非常によい −3
The evaluation is made according to the following evaluation criteria, and the values obtained by summing the evaluation scores are summarized in Table 7 below. (Evaluation Criteria) The Example is Better 3 The Example is Better 2 The Example is Better 1 No Difference 0 The Comparative Example Better -1 The Comparative Example Better- 2 The comparative example is much better -3

【0030】[0030]

【表7】 [Table 7]

【0031】上記チロシナーゼの活性抑制試験結果(表
1)、ヒアルロニダーゼ活性抑制試験結果(表2)、活
性酸素抑制試験結果(表3)、抗酸化試験(表4及び表
5)、使用テスト(表7)から明らかなように、本発明
のアダトダ・バシカの溶媒抽出物を含む化粧料は、チロ
シナーゼの活性、ヒアルロニダーゼの活性及び活性酸素
を抑制し、肌荒れ、肌のはりなどに有効なことが判っ
た。
Results of tyrosinase activity inhibition test (Table 1), hyaluronidase activity inhibition test result (Table 2), active oxygen inhibition test result (Table 3), antioxidant test (Tables 4 and 5), use test (Table) As is clear from 7), the cosmetic containing the solvent extract of Adatda vashika of the present invention inhibits the activity of tyrosinase, the activity of hyaluronidase and active oxygen, and is found to be effective for rough skin, skin blisters and the like. It was

【0032】[0032]

【発明の効果】本発明によれば、美白作用が高く、ヒア
ルロニダーゼの活性を抑制し、且つ肌荒れなどに有効な
安全性の高い化粧料が提供される。
EFFECTS OF THE INVENTION According to the present invention, there is provided a highly safe cosmetic composition which has a high whitening effect, suppresses the activity of hyaluronidase, and is effective against rough skin.

───────────────────────────────────────────────────── フロントページの続き (72)発明者 服部 征雄 富山県富山市五福末広町2556−4 2− 203 (72)発明者 下村 健次 三重県伊勢市船江3−16−32 (72)発明者 中村 雅美 三重県鳥羽市池上町6−32 ─────────────────────────────────────────────────── ─── Continuation of the front page (72) Inventor Masao Hattori 2556-4-22-203 Gofuku-Suehiro-cho, Toyama City, Toyama Prefecture (72) Inventor Kenji Shimomura 3-16-32 Funae, Ise City, Mie Prefecture Nakamura Masami 6-32 Ikegami Town, Toba City, Mie Prefecture

Claims (1)

【特許請求の範囲】[Claims] 【請求項1】 アダトダ・バシカ(Adhatoda vasica)
の溶媒抽出物を含む化粧料。
1. Adhatoda vasica
Cosmetics containing the solvent extract of.
JP26112893A 1993-10-19 1993-10-19 Cosmetics Expired - Fee Related JP3235919B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP26112893A JP3235919B2 (en) 1993-10-19 1993-10-19 Cosmetics

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP26112893A JP3235919B2 (en) 1993-10-19 1993-10-19 Cosmetics

Publications (2)

Publication Number Publication Date
JPH07118135A true JPH07118135A (en) 1995-05-09
JP3235919B2 JP3235919B2 (en) 2001-12-04

Family

ID=17357490

Family Applications (1)

Application Number Title Priority Date Filing Date
JP26112893A Expired - Fee Related JP3235919B2 (en) 1993-10-19 1993-10-19 Cosmetics

Country Status (1)

Country Link
JP (1) JP3235919B2 (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002114629A (en) * 2000-10-12 2002-04-16 Kyoei Kagaku Kogyo Kk Cosmetic
WO2002036138A1 (en) * 2000-10-31 2002-05-10 Emerald Forest Pharmaceuticals Pty Ltd A head lice formulation
US6455077B2 (en) * 2000-03-28 2002-09-24 Dabur Research Foundation Herbal composition and method of manufacturing such composition for the management of gynecological disorders
WO2014034802A1 (en) * 2012-08-29 2014-03-06 花王株式会社 Transglutaminase activator
JP2014062090A (en) * 2012-08-29 2014-04-10 Kao Corp Transglutaminase activator
JP2014139154A (en) * 2012-12-20 2014-07-31 Kao Corp Transglutaminase activator

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6455077B2 (en) * 2000-03-28 2002-09-24 Dabur Research Foundation Herbal composition and method of manufacturing such composition for the management of gynecological disorders
JP2002114629A (en) * 2000-10-12 2002-04-16 Kyoei Kagaku Kogyo Kk Cosmetic
WO2002036138A1 (en) * 2000-10-31 2002-05-10 Emerald Forest Pharmaceuticals Pty Ltd A head lice formulation
WO2014034802A1 (en) * 2012-08-29 2014-03-06 花王株式会社 Transglutaminase activator
JP2014062090A (en) * 2012-08-29 2014-04-10 Kao Corp Transglutaminase activator
US10064800B2 (en) 2012-08-29 2018-09-04 Kao Corporation Transglutaminase activator
JP2014139154A (en) * 2012-12-20 2014-07-31 Kao Corp Transglutaminase activator

Also Published As

Publication number Publication date
JP3235919B2 (en) 2001-12-04

Similar Documents

Publication Publication Date Title
JP3193441B2 (en) Whitening cosmetics
JP3558349B2 (en) Whitening cosmetics
JPH1025238A (en) Preparation for external use for skin
JP3235922B2 (en) Cosmetics
JP3170040B2 (en) Whitening cosmetics
JP3235919B2 (en) Cosmetics
JP3273812B2 (en) Cosmetics
JP3545057B2 (en) Cosmetics
JP3176983B2 (en) Whitening cosmetics
JPH05124952A (en) Cosmetic
JP3423074B2 (en) Cosmetics
JP3461921B2 (en) Cosmetics
JPH05155750A (en) Cosmetic
JP2001048768A (en) Cosmetic, quasi-drug, drug and food
JPH08217688A (en) Hyaluronidase inhibitor
JPH0597653A (en) Cosmetic
JP3233504B2 (en) Cosmetics
JPH0867617A (en) Cosmetic
JPH07126144A (en) Cosmetic
JP3206952B2 (en) Antioxidant
JP3547155B2 (en) Active oxygen suppressant
JP3792745B2 (en) Tyrosinase inhibitor
JPH0597649A (en) Cosmetic
JPH0592917A (en) Cosmetic
EP1009378A1 (en) Use of the rhoeo discolor plant extracts in cosmetics and pharmaceutics, in particular in dermatology

Legal Events

Date Code Title Description
R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313115

R371 Transfer withdrawn

Free format text: JAPANESE INTERMEDIATE CODE: R371

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313115

R360 Written notification for declining of transfer of rights

Free format text: JAPANESE INTERMEDIATE CODE: R360

R360 Written notification for declining of transfer of rights

Free format text: JAPANESE INTERMEDIATE CODE: R360

R371 Transfer withdrawn

Free format text: JAPANESE INTERMEDIATE CODE: R371

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313115

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

LAPS Cancellation because of no payment of annual fees